Separation Science, in collaboration with Phenomenex offers an on-demand webinar 'HPLC/UHPLC Reversed-Phase Method Development: Selecting a Reproducible Starting Point' with pharma industry expert, Dr Phil Koerner.
HPLC/UHPLC Reversed-Phase Method Development: Selecting a Reproducible Starting Point
presented by Dr. Philip J. Koerner (Global Pharmaceutical Industry Manager, Phenomenex)
Topics covered include:
- Particle Technology for HPLC vs UHPLC and LC/MS
- How to Improve Column Reproducibility
- A Look at a Diagnostic Case Study
- Benefits of Enhanced UHPLC and HPLC Column Reliability
- Chromatographic Solutions for Challenging Scenarios
- Retention of Polar Analytes Under "Typical" Conditions
- High pH Mobile Phases
- Orthogonal Selectivity
Who should view the presentation?
This webinar is recommended for anyone currently doing, will be doing or would like to gain a deeper understanding of HPLC or LC-MS method development, specifically on how to develop a reliable, reproducible and high throughput method. Different challenges and solutions will also be discussed.
About the presenter
Dr. Philip (Phil) J. Koerner is the Global Pharmaceutical Industry Manager with Phenomenex, located in Torrance, California, USA where he is accountable for developing, communicating, and leading strategic initiatives and integrated marketing programs globally to significantly increase Phenomenex’s presence in the pharmaceutical market.
Dr. Koerner has more than 30 years of experience in HPLC, GC, and sample preparation techniques; 11 years as a Senior Chemist with DuPont and 20 years with Phenomenex.
In his previous role as Senior Technical Manager at Phenomenex, Dr. Koerner traveled extensively around the world sharing his expertise and experience with customers in the form of technical seminars, hands-on training, and technical assistance covering various topics in HPLC, GC, and sample preparation.
He has also been an instructor for USP courses on General Chapters <467> (Residual Solvents) and <621> (Chromatography).
Dr. Koerner received his B.S. in Chemistry at the University of California, Irvine, earned his M.S. and Ph.D. in Chemistry at the University of Illinois, and an MBA at the University of Delaware.
